Alexander Bukreyev

12.3k citations

140 papers · 6.1k indexed · h-index 46

Impact in

Infectious Diseases top 0.2%
- Viral Infections and Outbreaks Research
- Viral Infections and Vectors
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
Epidemiology top 0.5%
- Respiratory viral infections research
- Virology and Viral Diseases
- Hepatitis B Virus Studies

Papers in

Infectious Diseases 120
- Viral Infections and Outbreaks Research 89
- Viral Infections and Vectors 73
- Viral gastroenteritis research and epidemiology 39
- SARS-CoV-2 and COVID-19 Research 19
Epidemiology 82
- Respiratory viral infections research 44
- Hepatitis B Virus Studies 25
- Virology and Viral Diseases 21

Co-authors: Peter L. Collins Brian R. Murphy Lijuan Yang Ursula J. Buchholz Kanta Subbarao Stephen S. Whitehead Philipp A. Ilinykh Patrick L. Collins
Journals: Journal of Virology (33 papers)PLoS Pathogens (9 papers)Cell Reports (8 papers)The Journal of Infectious Diseases (8 papers)Proceedings of the National Academy of Sciences (8 papers)
Partner nations: United States Russia United Kingdom

In The Last Decade

Alexander Bukreyev

138 papers receiving 6.0k citations

Peers

Countries citing papers authored by Alexander Bukreyev

Since Specialization

Citations

This map shows the geographic impact of Alexander Bukreyev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Bukreyev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Bukreyev more than expected).

Fields of papers citing papers by Alexander Bukreyev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Bukreyev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Bukreyev. The network helps show where Alexander Bukreyev may publish in the future.

Co-authors

The 25 scholars most cited alongside Alexander Bukreyev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alexander Bukreyev Line = papers co-authored together Alexander Bukreyev links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Distinct immune properties of the N- and C-termini of the immunosuppressive domain of Ebola virus glycoprotein mBio ·Mathieu Iampietro, Sivakumar Periasamy, Philipp A. Ilinykh, Yuan Qiu, Yakun Liu, Eisuke Nakazato, Bin Gong, Alexander Bukreyev	2025	1
2	Marburg virus glycoprotein mRNA vaccine is more protective than a virus-like particle-forming mRNA vaccine Journal of Clinical Investigation ·Chandru Subramani, Michelle Meyer, Nodirjon Ruzimurodov, Wenxin Zhang, Haiping Hao, James E. Crowe, Vsevolod L. Popov, Harshwardhan M. Thaker, Sunny Himansu, Andrea Carfı́, Alexander Bukreyev	2025	0
3	Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses Nature Communications ·Michelle Meyer, Bronwyn M. Gunn, Colette Pietzsch, Chandru Subramani, S.I. Chebykin, DJ Zimmermann, Nodirjon Ruzimurodov, Erica Ollmann Saphire, James E. Crowe, Galit Alter, Sunny Himansu, Andrea Carfı́, Alexander Bukreyev	2025	1
4	Ebola virus nucleoprotein interaction with host protein phosphatase-1 regulates its dimerization and capsid formation Journal of Biological Chemistry ·Chloe Lim, Bersabeh Tigabu, Christoph Jentsch, Marina Jerebtsova, Tatiana Ammosova, Palaniappan Ramanathan, Namita Kumari, Christine A. Brantner, Colette Pietzsch, L. V. Alacheva, S. Kassaye, Vladimir N. Uversky, Victor Paromov, Anastas Popratiloff, Hannah Cabasco, Alexander Bukreyev, Sergeï Nekhai	2025	0
5	Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24 Viruses ·Palaniappan Ramanathan, Bersabeh Tigabu, Rodrigo I. Santos, Philipp A. Ilinykh, Natalia A. Kuzmina, O. A. Vogel, 奥岡晋一, Derya Horasan, Chao Wu, Gaya K. Amarasinghe, Christopher F. Basler, Alexander Bukreyev	2023	2
6	Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking Nature Biotechnology ·Andrea R. Shiakolas, Kevin J. Kramer, Nicole V. Johnson, Glen Jacob, Naveenchandra Suryadevara, Daniel Wrapp, Sivakumar Periasamy, Kelsey A. Pilewski, Nagarajan Raju, Rachel S. Nargi, Rachel E. Sutton, Lauren Walker, Ian Setliff, James E. Crowe, Alexander Bukreyev, Robert H. Carnahan, Jason S. McLellan, Ivelin S. Georgiev	2022	27
7	Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region PLoS Pathogens ·Clara T. Schoeder, Pavlo Gilchuk, Amandeep K. Sangha, 杨晓玮, Delphine C. Malherbe, Xuan Zhang, Elad Binshtein, Lauren E. Williamson, Irensiana Pote, Jinhui Dong, Erica Armstrong, Rachel E. Sutton, Rachel S. Nargi, Jessica Rodríguez, Natalia A. Kuzmina, Brooke Fiala, Neil P. King, Alexander Bukreyev, James E. Crowe, Jens Meiler	2022	8
8	A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions Nature Communications ·Yang Liu, Xianwen Zhang, Jianying Liu, Hongjie Xia, Jing Zou, Antonio E. Muruato, Sivakumar Periasamy, Chaitanya Kurhade, Jessica A. Plante, Nathen E. Bopp, Birte Kalveram, Alexander Bukreyev, Ping Ren, Tian Wang, Vineet D. Menachery, Kenneth S. Plante, Xuping Xie, Scott C. Weaver, Pei‐Yong Shi	2022	62
9	Ubiquitination of Ebola virus VP35 at lysine 309 regulates viral transcription and assembly PLoS Pathogens ·Sarah van Tol, Birte Kalveram, Philipp A. Ilinykh, Adam J. Ronk, Kai Huang, Leopoldo Aguilera-Aguirre, Preeti Bharaj, Adam Hage, Colm Atkins, María I. Giraldo, Maki Wakamiya, Andreja Žele, A. Strubig, Alexander Bukreyev, Alexander N. Freiberg, Ricardo Rajsbaum	2022	16
10	Discovery of Marburg virus neutralizing antibodies from virus-naïve human antibody repertoires using large-scale structural predictions Proceedings of the National Academy of Sciences ·Nina G. Bozhanova, Amandeep K. Sangha, Alexander M. Sevy, Pavlo Gilchuk, Kai Huang, Rachel S. Nargi, Joseph X. Reidy, Andrew Trivette, Robert H. Carnahan, Alexander Bukreyev, James E. Crowe, Jens Meiler	2020	9
11	Small Molecule Compounds That Inhibit Antioxidant Response Gene Expression in an Inducer-Dependent Manner ACS Infectious Diseases ·Megan R. Edwards, Gai Liu, Haariss Khan, Julien Sourimant, Colette Pietzsch, Britney Johnson, Gaya K. Amarasinghe, Daisy W. Leung, Alexander Bukreyev, Richard K. Plemper, Zachary D. Aron, Terry L. Bowlin, Donald T. Moir, Christopher F. Basler	2020	1
12	Topoisomerase III-β is required for efficient replication of positive-sense RNA viruses Antiviral Research ·K. Reddisiva Prasanth, Minato Hirano, W. Samuel Fagg, Eileen T. McAnarney, Chao Shan, Xuping Xie, Adam Hage, Colette Pietzsch, Alexander Bukreyev, Ricardo Rajsbaum, Pei‐Yong Shi, Mark T. Bedford, Shelton S. Bradrick, Vineet D. Menachery, Mariano A. García-Blanco	2020	20
13	Annexin A2 depletion exacerbates the intracerebral microhemorrhage induced by acute rickettsia and Ebola virus infections PLoS neglected tropical diseases ·Інна Чуєва, Qing Chang, Aleksandra Drelich, Thomas R. Shelite, Barbara M. Judy, Yakun Liu, Le Guilloux, Kamontip Ploykrachang, Tomoya Ikuta, Yang Jin, Taís B. Saito, Shao‐Jun Tang, Lynn Soong, Maki Wakamiya, Xiang Fang, Alexander Bukreyev, Thomas G. Ksiazek, William K. Russell, Bin Gong	2020	9
14	Phosphorylated VP30 of Marburg Virus Is a Repressor of Transcription Journal of Virology ·Bersabeh Tigabu, Palaniappan Ramanathan, Andrey Ivanov, Xionghao Lin, Philipp A. Ilinykh, A P Atmaja, Alexander N. Freiberg, Sergeï Nekhai, Alexander Bukreyev	2018	20
15	Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses Antiviral Research ·Priya Luthra, Jacinth Naidoo, Colette Pietzsch, Haariss Khan, Sudip Khadka, Manu Anantpadma, Caroline G. Williams, Megan R. Edwards, Robert A. Davey, Alexander Bukreyev, Joseph M. Ready, Christopher F. Basler	2018	73
16	Adapting High-Throughput Screening Methods and Assays for Biocontainment Laboratories Assay and Drug Development Technologies ·Lynn Rasmussen, Bersabeh Tigabu, E. Lucile White, Robert Bostwick, Nski † Andkowalik, Alexander Bukreyev, Barry Rockx, James W. LeDuc, James W. Noah	2015	8
17	A BSL-4 High-Throughput Screen Identifies Sulfonamide Inhibitors of Nipah Virus Assay and Drug Development Technologies ·Bersabeh Tigabu, Lynn Rasmussen, E. Lucile White, Nski † Andkowalik, Mohammad Saeed, Alexander Bukreyev, Barry Rockx, James W. LeDuc, James W. Noah	2014	25
18	Expression of Interleukin-4 by Recombinant Respiratory Syncytial Virus Is Associated with Accelerated Inflammation and a Nonfunctional Cytotoxic T-Lymphocyte Response following Primary Infection but Not following Challenge with Wild-Type Virus Journal of Virology ·Alexander Bukreyev, Igor M. Belyakov, Gregory A. Prince, Kevin C. Yim, Julie Kling, Jay A. Berzofsky, Peter L. Collins	2005	21
19	More antibody with less antigen: Can immunogenicity of attenuated live virus vaccines be improved? Proceedings of the National Academy of Sciences ·Alexander Bukreyev, Mario H. Skiadopoulos, Josephine M. McAuliffe, Brian R. Murphy, Peter L. Collins, Alexander C. Schmidt	2002	11
20	Rational Design of Live-Attenuated Recombinant Vaccine Virus for Human Respiratory Syncytial Virus by Reverse Genetics Advances in virus research ·Peter L. Collins, Ala Nuseibah, Alexander Bukreyev, Rachel Fearns, Michael N. Teng, Katalin Juhász, Robert M. Chanock, Brian R. Murphy	1999	78

About Alexander Bukreyev

Alexander Bukreyev is a scholar working on Infectious Diseases, Epidemiology, Emergency Medical Services, Immunology and Animal Science and Zoology, having authored 140 papers that have together received 6.1k indexed citations. Recurring topics across this work include Viral Infections and Outbreaks Research (89 papers), Viral Infections and Vectors (73 papers), Respiratory viral infections research (44 papers), Viral gastroenteritis research and epidemiology (39 papers), Hepatitis B Virus Studies (25 papers), Virology and Viral Diseases (21 papers), SARS-CoV-2 and COVID-19 Research (19 papers) and Immune Cell Function and Interaction (11 papers). The work is most often cited by research in Infectious Diseases (4.0k citations), Epidemiology (3.2k citations), Animal Science and Zoology (845 citations), Immunology (1.0k citations) and Virology (182 citations). Alexander Bukreyev has collaborated with scholars based in United States, Russia and United Kingdom. Frequent co-authors include Peter L. Collins, Brian R. Murphy, Lijuan Yang, Ursula J. Buchholz, Kanta Subbarao, Stephen S. Whitehead, Philipp A. Ilinykh, Patrick L. Collins, Palaniappan Ramanathan and Leatrice Vogel. Their work appears in journals such as Journal of Virology, PLoS Pathogens, Cell Reports, The Journal of Infectious Diseases and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact